The Framingham study reported that inflammatory markers (such as C-reactive protein, interleukin-6, and fibrinogen) were associated with the risk of ischemic stroke recurrence and transient ischemic attack (22, 23). The gene discussed is IL6; the disease is transient ischemic attack.